HCPCS Level II · Drugs administered other than oral method
J2840Injection, sebelipase alfa, 1 mg
✓ Active
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About J2840
J2840 is an HCPCS Level II code in the J series (drugs administered other than oral method), describing injection, sebelipase alfa, 1 mg.
It was added to HCPCS effective 01/01/2017.
Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.
Details
- Short description
- Inj sebelipase alfa 1 mg
- Date added
- 01/01/2017
- Action effective
- 01/01/2017
- BETOS
- O1E
Related J28xx codes
- J2800Injection, methocarbamol, up to 10 ml
- J2801Injection, risperidone (rykindo), 0.5 mg
- J2802Injection, romiplostim, 1 microgram
- J2804Injection, rifampin, 1 mg
- J2805Injection, sincalide, 5 micrograms
- J2810Injection, theophylline, per 40 mg
- J2820Injection, sargramostim (gm-csf), 50 mcg
- J2850Injection, secretin, synthetic, human, 1 microgram
- J2860Injection, siltuximab, 10 mg
- J2865Injection, sulfamethoxazole 5 mg and trimethoprim 1 mg
Common questions about J2840
Is HCPCS J2840 still valid?
- Yes. J2840 is active in the CMS October 2026 HCPCS file.
Does Medicare cover J2840?
- Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.